SAMN38144544
External Id
dbGaP
INSDC center name
2023-11-07T12:14:06.970Z
INSDC first public
2024-05-30T05:49:34.837Z
INSDC last update
SRS19518520
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS19518520
SRA accession
NCI_Pembrolizumab_MIBC
biospecimen repository
patient_111_Tumor_Post_WES
biospecimen repository sample id
Urinary Bladder Tumor
body site
phs003452
gap_accession
1
gap_consent_code
DS-CA
gap_consent_short_name
5699489
gap_sample_id
4644990
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Case Set
study design
Urinary Bladder Neoplasms
study disease
Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy
study name
Yes
subject is affected
patient_111_Tumor_Post_WES
submitted sample id
patient_111
submitted subject id
NCI_Pembrolizumab_MIBC
submitter handle
Urinary Bladder Neoplasms tumor sample from Urinary Bladder Tumor of a human male participant in the dbGaP study "Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy"
title